Cargando…
Secretogranin II impairs tumor growth and angiogenesis by promoting degradation of hypoxia‐inducible factor‐1α in colorectal cancer
Distant metastasis is a major cause of death in patients with colorectal cancer (CRC) but the management of advanced and metastatic CRC still remains problematic due to the distinct molecular alterations during tumor progression. Tumor angiogenesis is a key step in tumor growth, invasion and metasta...
Autores principales: | Fang, Chao, Dai, Lei, Wang, Cun, Fan, Chuanwen, Yu, Yongyang, Yang, Lie, Deng, Hongxin, Zhou, Zongguang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8637574/ https://www.ncbi.nlm.nih.gov/pubmed/34160138 http://dx.doi.org/10.1002/1878-0261.13044 |
Ejemplares similares
-
Prognostic value of CD133(+)
CD54(+)
CD44(+) circulating tumor cells in colorectal cancer with liver metastasis
por: Fang, Chao, et al.
Publicado: (2017) -
CD133(+)CD54(+)CD44(+) circulating tumor cells as a biomarker of treatment selection and liver metastasis in patients with colorectal cancer
por: Fang, Chao, et al.
Publicado: (2016) -
Regulatory Peptides from Chromogranin A and Secretogranin II
por: Helle, Karen B.
Publicado: (2010) -
Potential therapeutic target secretogranin II might cooperate with hypoxia‐inducible factor 1α in sunitinib‐resistant renal cell carcinoma
por: Fukumoto, Wataru, et al.
Publicado: (2023) -
Rectal Cancer in West China: Younger Onset, Poor Survival, and Poor Compliance
por: Fang, Chao, et al.
Publicado: (2021)